Drugmakers’ stocks were leading the Dow and S&P 500 decliners after President Trump said tariffs on pharmaceuticals will be ...

generic drugs market is fueled by patent expirations, increasing healthcare costs, and the rising global demand for affordable medications.

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

The market might have been better able to swallow the looming ... rather than imposing the full amounts straight away. The pharmaceutical industry is particularly vulnerable to levies on foreign ...

Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on ...